Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review
Transplant Infectious Disease · 2023-04 · 25 (2)
DOI: 10.1111/tid.14028 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Transplant Infectious Disease, online erschienen am 07.02.2023. Verfasst von Malcolm Holterhus und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatric Hematology and Oncology, University Children's Hospital Munster, Munster, Germany. Hauptthemen laut MEDLINE: Erythema Infectiosum, Parvoviridae Infections, Hematopoietic Stem Cell Transplantation, Parvovirus B19, Human. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Parvovirus B19 (B19V) infection following pediatric hematopoietic cell transplantation (HCT) is a rare complication and available data is scarce. Therefore, we present the experience with B19V Infection in allogeneic pediatric HCT recipients at our transplant center together with a systematic review of the literature.
Methods
Pediatric HCT patients with Parvovirus B19 infection treated at the University Children's Hospital Münster between 1999 and 2021 were retrospectively identified and clinical data were analyzed. Additionally, a systematic MEDLINE search to identify relevant articles was performed.
Results
We identified three out of 445 patients (0.6%) with B19V infection post‐transplantation. B19V infection occurred in combination with other complications like Graft‐versus‐Host disease, additional infections, or autoimmune‐mediated hemolysis potentially triggered by B19V. In one patient these complications lead to a fatal outcome. The review of the literature showed considerable morbidity of B19V infection with the potential for life‐threatening complications. Most patients were treated by red blood cell transfusion and intravenous immunoglobulins (IVIG) with a high succession rate.
Conclusion
Symptomatic B19V infection following HCT remains a rare but potentially challenging complication. A causal antiviral therapy does not exist as well as general recommendations on dosage and duration of IVIG therapy. Despite this, most patients are treated successfully with these measures. Additionally, transmission via blood or stem cell products is also rare and no general recommendations on B19V screenings exist. image
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatric Hematology and Oncology, University Children's Hospital Munster, Munster, Germany.
- Department for Clinical Virology, Institute of Virology, University Hospital Munster, Munster, Germany.
- Department of Transfusion Medicine and Cellular Therapy, University Hospital Munster, Munster, Germany.
- Department of Pediatric Hematology and Oncology, Infectious Disease Research Program, Center for Bone Marrow Transplantation, University Children's Hospital Münster, Munster, Germany.
ORCID-Profile: Malcolm Holterhus, Andreas H Groll
Zitieren
APA
Holterhus, M., Hennies, M., Hillmann, H., Thorer, H., Rossig, C., Burkhardt, B., & Groll, A. H. (2023). Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review. Transplant Infectious Disease, 25(2). https://doi.org/10.1111/tid.14028
Vancouver
Holterhus M, Hennies M, Hillmann H, Thorer H, Rossig C, Burkhardt B, et al. Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review. Transplant Infectious Disease. 2023;25(2). doi:10.1111/tid.14028
BibTeX
@article{Holterhus2023,
author = {Holterhus, Malcolm and Hennies, Marc and Hillmann, Hartmut and Thorer, Heike and Rossig, Claudia and Burkhardt, Birgit and Groll, Andreas H},
title = {Parvovirus B19 infection in pediatric allogeneic hematopoietic cell transplantation – Single‐center experience and review},
journal = {Transplant Infectious Disease},
year = {2023},
volume = {25},
number = {2},
doi = {10.1111/tid.14028}
}
EUVIMED